Glyscend Therapeutics
Baltimore, United States· Est. 2015
Mimicking the effect of bariatric surgery with an oral pill. Glyscend’s dynamic barrier approach seeks to provide the benefits of gastric...
Private Company
Total funding raised: $62.5M
About
Mimicking the effect of bariatric surgery with an oral pill. Glyscend’s dynamic barrier approach seeks to provide the benefits of gastric...
MetabolicDrug Delivery
Funding History
2Total raised:$62.5M
Series B$40MJan 15, 2022
Series A$22.5MOct 15, 2020